Your browser doesn't support javascript.
Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.
Naci, Huseyin; Kesselheim, Aaron S; Røttingen, John-Arne; Salanti, Georgia; Vandvik, Per O; Cipriani, Andrea.
  • Naci H; Department of Health Policy, London School of Economics and Political Science, London, UK h.naci@lse.ac.uk.
  • Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Røttingen JA; Research Council of Norway, Oslo, Norway.
  • Salanti G; Blavatnik School of Government, University of Oxford, Oxford, UK.
  • Vandvik PO; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Cipriani A; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
BMJ ; 371: m3869, 2020 10 16.
Article in English | MEDLINE | ID: covidwho-873514

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Evidence-Based Medicine / Quality Improvement / Pandemics / Drug Development Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Bmj.m3869

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Evidence-Based Medicine / Quality Improvement / Pandemics / Drug Development Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Bmj.m3869